Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Caliway Announces the Initiation of Subject Recruitment in CBL-514 Phase 2b Study for Dercum's Disease
2024-09-03 15:18
Simcere Zaiming collaborates with TargetRx to introduce a third-generation ALK inhibitor
2024-09-02 20:24
Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor JAB-3312 to Allist in China
2024-08-30 19:34
Breaking News | Sanyou Bio Launches Comprehensive Monkeypox Product Line
2024-08-30 18:00
/DISREGARD RELEASE: Celltrion USA/
2024-08-30 08:35
CARsgen® Announces 2024 Interim Results
2024-08-29 20:50
Medicilon Expands Global Presence with Official Opening of Second R&D Center in Massachusetts
2024-08-29 20:30
Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results
2024-08-29 14:31
Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization
2024-08-29 04:20
Asieris Pharmaceuticals Releases 2024 Semi-Annual Report, Highlighting Steady Progress in Launching Blockbuster Product for Precancerous Cervical Lesions and Continued Strengthening of Commercial Revenue Generation Capabilities
2024-08-28 21:34
Jenscare, with innovative TTVR, releases 2024H1 interim results
2024-08-28 21:00
Tigermed Reports 2024 Interim Results
2024-08-28 18:26
Fosun Pharma Announces 2024 Interim Results
2024-08-28 18:10
Harbour BioMed Announces 2024 Interim Results
2024-08-28 17:44
Hyundai Bioscience to conduct phase 3 clinical trial for high-risk group of COVID-19 patients with the goal of emergency use authorization
2024-08-28 17:29
Achieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical
2024-08-28 16:40
Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist
2024-08-28 10:43
GenScript Subsidiary Legend Biotech Achieves Breakthrough with Cilta-cel Approval in China, Offering New Hope for Multiple Myeloma Patients
2024-08-27 22:28
Keymed Biosciences Announces Interim Results for First Half of 2024
2024-08-27 21:10
Sleep Specialists and Industry Leaders Converge at HoneyNaps Symposium
2024-08-27 21:00
1
13
14
15
16
17
431